Simile has raised more than $200 million in Series B funding at a $2 billion post-money valuation, providing the Palo Alto-based startup with substantial capital to develop artificial intelligence models designed to simulate how people make decisions. Greenoaks led the round, while existing investor Index Ventures increased its backing. Hanabi, Bain Capital Ventures, A*, Factory and CVS Health Ventures also returned, with Definition joining as a new investor. The financing arrives only five…